[HTML][HTML] Platelet receptors and signaling in the dynamics of thrombus formation

J Rivera, ML Lozano, L Navarro-Núñez, V Vicente - haematologica, 2009 - ncbi.nlm.nih.gov
Hemostasis and pathological thrombus formation are dynamic processes that require a co-
ordinated series of events involving platelet membrane receptors, bidirectional intracellular …

Hemostatic risk factors and arterial thrombotic disease

AP Reiner, DS Siscovick… - Thrombosis and …, 2001 - thieme-connect.com
The pathogenesis of arterial thrombotic disease involves multiple genetic and environmental
factors related to atherosclerosis and thrombosis. Acute thrombosis at the site of a ruptured …

Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100®

M Homoncik, B Jilma, N Hergovich… - Thrombosis and …, 2000 - thieme-connect.com
Anti-platelet drug therapy is currently performed without monitoring, because the established
method of platelet aggregometry is cumbersome. The recently developed platelet function …

Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms

L Macchi, L Christiaens, S Brabant, N Sorel… - Journal of the American …, 2003 - jacc.org
Objectives: We investigated whether three platelet gene polymorphisms, PlA1/A2, C807T,
and C-5T Kozak (encoding, respectively, for platelet membrane glycoproteins (GP) IIIa, GP …

Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure?

R Gonzalez-Conejero, J Rivera, J Corral, C Acuna… - Stroke, 2005 - Am Heart Assoc
Background and Purpose—The widespread use of aspirin requires clarification of the
aspirin resistance phenomenon. Most studies on this field are focused on patients which …

Pharmacogenetics in cardiovascular antithrombotic therapy

F Marín, R González-Conejero, P Capranzano… - Journal of the American …, 2009 - jacc.org
Thrombosis is the most important underlying mechanism of coronary artery disease and
embolic stroke. Hence, antithrombotic therapy is widely used in these scenarios. However …

An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN

A Dupont, P Fontana, C Bachelot-Loza… - Blood, The Journal …, 2003 - ashpublications.org
Protease-activated receptor 1 (PAR-1), the main thrombin receptor on vascular cells, plays a
key role in platelet activation. We examined the range of PAR-1 expression on platelets …

The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease

TJ Kunicki - Arteriosclerosis, thrombosis, and vascular biology, 2002 - Am Heart Assoc
Extracellular collagens modulate the rate of platelet activation and thereby markedly
influence hemostasis and thrombosis. Platelet receptors for collagens, such as the integrin …

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions

PJ Williams, L Morgan - Pharmacogenomics and personalized …, 2012 - Taylor & Francis
The pregnancy-specific condition pre-eclampsia not only affects the health of mother and
baby during pregnancy but also has long-term consequences, increasing the chances of …

Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors

S Stankovic, N Majkic-Singh - Critical Reviews in Clinical …, 2010 - Taylor & Francis
Stroke is one of the most common causes of death and long term disability throughout the
world. It may be the outcome of a number of monogenic disorders or, more commonly, a …